Literature DB >> 27207567

Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients.

Paolo Sfriso1, Roberta Priori2, Guido Valesini2, Silvia Rossi3, Carlo Maurizio Montecucco3, Anna D'Ascanio4, Linda Carli4, Stefano Bombardieri4, Gaetana LaSelva5, Florenzo Iannone5, Giovanni Lapadula5, Stefano Alivernini6, Gianfranco Ferraccioli6, Michele Colaci7, Clodoveo Ferri7, Daniela Iacono8, Gabriele Valentini8, Luisa Costa9, Raffaele Scarpa9, Andrea LoMonaco10, Valentina Bagnari10, Marcello Govoni10, Ilaria Piazza11, Silvano Adami11, Francesco Ciccia12, Giovanni Triolo12, Elisa Alessandri13, Maurizio Cutolo13, Luca Cantarini14, Mauro Galeazzi14, Piero Ruscitti15, Roberto Giacomelli15, Francesco Caso16,9, Paola Galozzi16, Leonardo Punzi16.   

Abstract

Adult-onset Still's disease (AOSD) is a systemic inflammatory condition of unknown aetiology characterized by typical episodes of spiking fever, evanescent rash, arthralgia, leukocytosis and hyperferritinemia. Given the lack of data in Italian series, we promote a multicentric data collection to characterize the clinical phenotype of Italian patients with AOSD. Data from 245 subjects diagnosed with AOSD were collected by 15 centres between March and May 2013. The diagnosis was made following Yamaguchi's criteria. Data regarding clinical manifestations, laboratory features, disease course and treatments were reported and compared with those presented in other published series of different ethnicity. The most frequent features were the following: arthritis (93 %), pyrexia (92.6 %), leukocytosis (89 %), negative ANA (90.4 %) and neutrophilia (82 %). As compared to other North American, North European, Middle Eastern and Far Eastern cohorts, Italian data show differences in clinical and laboratory findings. Regarding the treatments, in 21.9 % of cases, corticosteroids and traditional DMARDs have not been able to control the disease while biologics have been shown to be effective in 48 to 58 patients. This retrospective work summarizes the largest Italian multicentre series of AOSD patients and presents clinical and laboratory features that appear to be influenced by the ethnicity of the affected subjects.

Entities:  

Keywords:  Adult-onset Still’s disease; Biologic drugs; Clinical presentation; Laboratory findings; Retrospective study

Mesh:

Substances:

Year:  2016        PMID: 27207567     DOI: 10.1007/s10067-016-3308-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  28 in total

1.  Intravenous methylprednisolone pulse therapy in Still's disease.

Authors:  A Bisagni-Faure; C Job-Deslandre; C J Menkes
Journal:  J Rheumatol       Date:  1992-09       Impact factor: 4.666

2.  Clinical features and prognosis in adult-onset Still's disease: a study of 104 cases.

Authors:  Xiao-Dan Kong; Dong Xu; Wen Zhang; Yan Zhao; Xiaofeng Zeng; Fengchun Zhang
Journal:  Clin Rheumatol       Date:  2010-06-14       Impact factor: 2.980

3.  A retrospective study of patients with adult-onset Still's disease: is pericarditis a possible predictor for biological disease-modifying anti-rheumatic drugs need?

Authors:  Francesca Dall'Ara; Micol Frassi; Angela Tincani; Paolo Airò
Journal:  Clin Rheumatol       Date:  2016-01-12       Impact factor: 2.980

4.  Prolonged efficacy of infliximab for refractory adult-onset Still's disease.

Authors:  M S Dilhuydy; R Vatan; G Etienne; M Longy-Boursier; P Mercié
Journal:  Clin Exp Rheumatol       Date:  2005 Jan-Feb       Impact factor: 4.473

5.  Preliminary criteria for classification of adult Still's disease.

Authors:  M Yamaguchi; A Ohta; T Tsunematsu; R Kasukawa; Y Mizushima; H Kashiwagi; S Kashiwazaki; K Tanimoto; Y Matsumoto; T Ota
Journal:  J Rheumatol       Date:  1992-03       Impact factor: 4.666

6.  On a Form of Chronic Joint Disease in Children.

Authors:  G F Still
Journal:  Med Chir Trans       Date:  1897

7.  Still's disease in the adult.

Authors:  E G Bywaters
Journal:  Ann Rheum Dis       Date:  1971-03       Impact factor: 19.103

8.  Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease.

Authors:  B Fautrel; C Borget; S Rozenberg; O Meyer; X Le Loët; C Masson; A C Koeger; M F Kahn; P Bourgeois
Journal:  J Rheumatol       Date:  1999-02       Impact factor: 4.666

9.  Clinical characteristics and follow-up analysis of adult-onset Still's disease complicated by hemophagocytic lymphohistiocytosis.

Authors:  Yun Zhang; Yingyun Yang; Yujia Bai; Dan Yang; Yangyang Xiong; Xuejun Zeng
Journal:  Clin Rheumatol       Date:  2016-01-26       Impact factor: 2.980

10.  Adult-onset Still's disease. Clinical course and outcome.

Authors:  J J Cush; T A Medsger; W C Christy; D C Herbert; L A Cooperstein
Journal:  Arthritis Rheum       Date:  1987-02
View more
  34 in total

1.  Identification of prognostic factors and construction of a nomogram for patients with relapse/refractory adult-onset Still's disease.

Authors:  Ruxue Yin; Gangjian Wang; Xiaopei Yang; Lei Zhang; Shuolin Wang; Tianfang Li; Shengyun Liu
Journal:  Clin Rheumatol       Date:  2021-05-18       Impact factor: 2.980

Review 2.  Adult-Onset Still's Disease: Molecular Pathophysiology and Therapeutic Advances.

Authors:  Paolo Sfriso; Sara Bindoli; Paola Galozzi
Journal:  Drugs       Date:  2018-08       Impact factor: 9.546

3.  Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients.

Authors:  Piero Ruscitti; Carmela Rago; Luciana Breda; Paola Cipriani; Vasiliki Liakouli; Onorina Berardicurti; Francesco Carubbi; Caterina Di Battista; Alberto Verrotti; Roberto Giacomelli
Journal:  Clin Rheumatol       Date:  2017-09-15       Impact factor: 2.980

4.  Clinical characteristics and comorbidities in adult-onset Still's disease using a large US administrative claims database.

Authors:  Aleksander Lenert; GYeon Oh; Michael J Ombrello; Sujin Kim
Journal:  Rheumatology (Oxford)       Date:  2020-07-01       Impact factor: 7.580

5.  Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort.

Authors:  Piero Ruscitti; Paola Cipriani; Vasiliki Liakouli; Daniela Iacono; Ilenia Pantano; Francesco Caso; Federico Perosa; Fabiola Atzeni; Francesco Paolo Cantatore; Raffaele Scarpa; Francesco Ciccia; Roberto Giacomelli
Journal:  Rheumatol Int       Date:  2019-07-01       Impact factor: 2.631

Review 6.  [Still's syndrome-similarities and differences between the juvenile and adult forms].

Authors:  Andrea Regel; Dirk Föll; Martin A Kriegel
Journal:  Z Rheumatol       Date:  2021-11-04       Impact factor: 1.372

7.  Association Between Peripheral Eosinophilia and Clinical Characteristics of Adult-onset Still's Disease with Persistent Eruption: A Retrospective Study.

Authors:  Jia-Wei Liu; Tian Chen; Wei Liu; Ru-Xuan Chen; Yue-Tong Qian; Yan Tan; Dong-Lai Ma
Journal:  Acta Derm Venereol       Date:  2021-09-28       Impact factor: 3.875

Review 8.  From autoinflammation to autoimmunity: old and recent findings.

Authors:  Francesco Caso; Luisa Costa; Valeria Nucera; Giuseppe Barilaro; Ignazio Francesco Masala; Rossella Talotta; Paolo Caso; Raffaele Scarpa; Piercarlo Sarzi-Puttini; Fabiola Atzeni
Journal:  Clin Rheumatol       Date:  2018-07-16       Impact factor: 2.980

9.  H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome.

Authors:  P Ruscitti; P Cipriani; P Di Benedetto; V Liakouli; O Berardicurti; F Carubbi; F Ciccia; G Guggino; G Triolo; R Giacomelli
Journal:  Clin Exp Immunol       Date:  2017-10-20       Impact factor: 4.330

Review 10.  Myocarditis in Adult-Onset Still's Disease: Case-Based Review.

Authors:  Abraham Edgar Gracia-Ramos; Joshua Antonio Contreras-Ortíz
Journal:  Clin Rheumatol       Date:  2019-11-20       Impact factor: 3.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.